Financial Constraints to Molecular Biomarker Testing
Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video LibraryDrs. David Rimm and Roy Herbst discuss the challenges of reimbursement by payers and the costs to pathology department of molecular biomarker testing, especially immunohistochemistry and DNA testing.
Related Videos
Absorbing the Cost of Personalized Medicine
Matthew Palmgren discusses the benefits of personalized medicines
Providing the Right Information on Target Therapy to the Oncology Community
Dr Agarwala discusses the optimal approach to providing information on targeted therapies to the oncology community.